Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
87 participants
INTERVENTIONAL
2015-07-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Bubble Continuous Positive Airway Pressure Compared to Nasal Prong Oxygen or Humidified High Flow in Children Under Five With Severe Pneumonia and Hypoxaemia
NCT01396759
Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia
NCT03870243
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
NCT03944551
CPAP Improving Mortality for Pneumonia in African Children Trial
NCT02484183
Heated High Flow Oxygen Use in Infants With Bronchiolitis and Hypoxia
NCT01662544
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bubble CPAP
Bubble CPAP for 28 days
Bubble CPAP
Respiratory assistance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bubble CPAP
Respiratory assistance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Congenital lung disease
* Cyanotic heart disease
* Nasal trauma/facial injury/congenital anomaly (cleft) that makes bubble CPAP nasal interface unusable
* Nasal tissue injury
* Active nosebleed
* Recent abdominal surgery or significant abdominal distension
* Agonal respirations
* GCS \<3
* Imminent death within the next 1-2hou
1 Month
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashley Bjorklund, MD
Role: STUDY_DIRECTOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gulu Regional Referral Hospital
Gulu, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12985
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
1406M51386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.